EverSource Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Sell
28,598
-7,572
-21% -$435K 0.06% 249
2026
Q1
$2.19M Buy
36,170
+7,313
+25% +$426K 0.07% 209
2025
Q4
$1.56M Buy
28,857
+19,794
+218% +$952K 0.06% 239
2025
Q3
$409K Buy
9,063
+1,632
+22% +$76.2K 0.02% 581
2025
Q2
$344K Buy
7,431
+292
+4% +$14.3K 0.02% 602
2025
Q1
$435K Sell
7,139
-465
-6% -$27.1K 0.02% 416
2024
Q4
$430K Buy
7,604
+1,015
+15% +$56.7K 0.02% 405
2024
Q3
$341K Buy
6,589
+894
+16% +$41.9K 0.02% 414
2024
Q2
$271K Buy
5,695
+703
+14% +$31.5K 0.02% 469
2024
Q1
$219K Buy
4,992
+2,431
+95% +$124K 0.02% 459
2023
Q4
$131K Sell
2,561
-2,054
-45% -$108K 0.01% 550
2023
Q3
$268K Buy
4,615
+881
+24% +$54K 0.03% 338
2023
Q2
$239K Sell
3,734
-940
-20% -$63K 0.03% 363
2023
Q1
$324K Sell
4,674
-1,081
-19% -$76.2K 0.04% 285
2022
Q4
$414K Buy
5,755
+1,622
+39% +$122K 0.06% 226
2022
Q3
$295K Sell
4,133
-634
-13% -$46K 0.07% 242
2022
Q2
$367K Buy
4,767
+3,834
+411% +$292K 0.09% 188
2022
Q1
$68K Buy
933
+210
+29% +$14.1K 0.02% 413
2021
Q4
$45K Buy
+723
New +$42.4K 0.01% 446

Other funds holding BMY

EverSource Wealth Advisors's BMY Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 21% in Q2 2026, selling an estimated $435K and leaving 28,598 shares worth $1.65M. The position accounts for 0.06% of the portfolio, ranked #249.

EverSource Wealth Advisors first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.19M in Q1 2026. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • EverSource Wealth Advisors held 28,598 shares of Bristol-Myers Squibb worth $1.65M as of Q2 2026.
  • EverSource Wealth Advisors sold 7,572 Bristol-Myers Squibb shares in Q2 2026, an estimated $435K.
  • Bristol-Myers Squibb made up 0.06% of EverSource Wealth Advisors's portfolio in Q2 2026, its #249 holding.
  • EverSource Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Bristol-Myers Squibb position peaked at $2.19M in Q1 2026.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.